In Vitro Susceptibility of piperacillin/tazobactam Against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
- Author:
Eui Chong KIM
1
Author Information
- Publication Type:In Vitro ; Note
- Keywords: Piperacillin/tazobactam; ESBL-producing E. coli; ESBL-producing K. pneumoniae
- MeSH: beta-Lactamases; Escherichia; Escherichia coli; Klebsiella; Klebsiella pneumoniae; Pneumonia; Polymerase Chain Reaction
- From: Infection and Chemotherapy 2008;40(1):49-51
- CountryRepublic of Korea
- Language:Korean
- Abstract: Minimal inhibitory concentrations (MIC) of piperacillin/tazobactam were determined on 20 clinical isolates of extended-spectrum beta-lactamase (ESBL)-producing E. coli and 30 isolates of ESBL- producing Klebsiella pneumoniae. MIC50 and MIC90 for ESBL-producing E. coli were 8/4 microg/ml and 256/4 microg/mL, respectively. MIC50 and MIC90 for ESBL-producing K. pneumoniae were 8/4 microg/mL and > 512/4 microg/mL, respectively. The susceptibilities of ESBL-producing E. coli and K. pneumoniae to piperacillin/tazobactam were 80% and 60%, respectively. Of 20 ESBL-producing E. coli strains, 11 (55%) were TEM-and CTX-M-positive, and SHV-negative. Of 30 ESBL-producing K. pneumoniae strains, ten (33%) were PCR positive for SHV and negative for TEM and CTX-M.
